Why It Took So Long for the FDA to Tackle a Cold Medicine
Pharmacists affiliated with the University of Florida have spent decades nudging the agency to pull a decongestant from over-the-counter medicines.
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.
MDMA Therapy for PTSD Inches Closer to U.S. Approval
Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.
Nuevas vacunas contra la covid en EE. UU.: lo que hay que saber
Las nuevas formulaciones puede ayudar a combatir mejor el más reciente grupo de subvariantes que circulan en Estados Unidos.
A Decongestant in Cold Medicines Is Ineffective. Here’s What to Use Instead.
Here’s what you can use instead.
Decongestant in Cold Medicines Doesn’t Work, Panel Says
The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold.
C.D.C. Advisers to Decide Who Should Receive New Covid Vaccines
Scientists will meet on Tuesday to consider data on newly approved shots from Pfizer and Moderna.
New Covid Vaccine: What to Know About the Monovalent Booster
The updated vaccines could become available within a few days.
Treating Overdoses Over the Counter
It is now easier than ever to get a medication that stops overdoses.
Covid Vaccines May Roll Out Within Days
The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.